Silence Therapeutics PLC (ADR) - SLN - stock price prediction, stock price target, analyst ratings from 6 analysts

Silence Therapeutics PLC (ADR) has a share price target of US$ 34, revenue growth forecast of -80.7%, and profit growth estimate of -140.3% for FY25, based on top 6 analyst calls.